Mice null for the Pms2 mismatch repair (MMR) gene exhibit a predisposition to lymphoma, microsatellite repeat instability, and failure of spermatogenesis. To study the role of Pms2 in the maintenance of in vivo genomic integrity in somatic cells, we characterized Aprt mutations in T cells and ®broblasts of 1296C3H Pms2
Introduction
DNA mismatch repair (MMR) proteins contribute to the maintenance of genomic integrity in multiple pathways (Modrich and Lahue, 1996, Kolodner and Marsischky, 1999; Buermeyer et al., 1999, Harfe and Jinks-Robertson, 2000) . First, MMR corrects mispaired or extrahelical nucleotides that are infrequently introduced during DNA replication, by mis-incorporation or by slippage. Second, MMR-mediated suppression of recombination is believed to reduce the incidence of both translocation and mitotic recombination (Harfe and Jinks-Robertson, 2000) . Third, MMR plays a role in the regulation of apoptosis (Gong et al., 1999; Toft et al., 1999; Zhang et al., 1999; Zeng et al., 2000) . In the absence of MMR, apoptosis is compromised in cells with DNA damage, and the increased chance of survival and proliferation of those cells may allow further accumulation of mutations.
Organisms and cells that are MMR-de®cient typically exhibit an increased level of genetic instability, or a mutator phenotype. The mutator phenotype includes instability of microsatellite repeats, elevation of point mutation and increase of recombination between divergent sequences (homeologous recombination). In humans, MMR-de®ciency can lead to several types of cancer. For example, inherited mutations in a subset of MMR genes, including MSH2, MLH1 and PMS2, are responsible for hereditary non-polyposis colorectal cancer (HNPCC).
To elucidate the biological functions of the MMR genes in vivo, mouse mutants of various MMR homologs have been generated through targeted gene disruption in embryonic stem cells. Depending on the MMR gene, the homozygous mutant mice displayed one, two or all of the following three phenotypes : (i) tumor predisposition, (ii) mutator phenotype, and (iii) meiotic defect(s). For example, Mlh1 7/7 mice exhibit all three phenotypes, whereas Pms1 7/7 mice only show a mild mutator phenotype.
Most studies of the mutator phenotype in MMRde®cient mice were based on observations of microsatellite repeat markers (Yao et al., 1999) or bacterial transgenes, such as supF (Narayanan et al., 1997) , lacI and cII (Andrew et al., 1997 (Andrew et al., , 2000 Baross-Francis et al., 2001) . However, microsatellite repeat markers only re¯ect frameshift changes in sequences containing mono-or dinucleotide repeats. While bacterial transgenes can show base substitutions, frameshifts and other intragenic alterations, there are concerns as to whether or not their behavior mimics that of endogenous genes since they usually reside as multiple copies in a host cell, are hypermethylated and transcriptionally inactive (Mirsalis et al., 1995) . We have documented the use of an endogenous, and ubiquitously expressed, APRT (adenine phosphoribo-syltransferase) gene as a reporter for loss of heterozygosity (LOH) in vivo (Shao et al., 1999 (Shao et al., , 2000 (Shao et al., , 2001 . Because Aprt is autosomal, it can detect most genetic alterations at the chromosome level, such as mitotic recombination and multi-loci deletion, in addition to intragenic mutations and small deletions. In this study, we characterized somatic mutations at Aprt in normal T lymphocytes and ®broblasts of 1296C3H Pms2 7/7 Aprt +/7 mice. (Figure 1 ). We divided the DAP r clones into two classes according to the absence or retention of the untargeted Aprt allele (Shao et al., 1999) . Class I variants, those exhibiting loss of the untargeted Aprt, were predominant in Pms2 +/+ mice (40/46, 87%), which is consistent with our previous study (Shao et al., 2000) . However, class I clones, those retaining the untargeted allele, replaced class I as the primary cause of APRTde®ciency in Pms2 7/7 mice (110/170, 65%) ( Table 1 ).
Results

T cells of Pms2
The shift of the mutational spectrum between the two groups is highly signi®cant (P50.0001). Analysis of anking SSLP showed that almost all of the class I variants in either Pms2 +/+ or Pms2 7/7 mice were derived from mitotic recombination ( (Shao et al., 1999 , Rose et al., 2000 . We sequenced all ®ve exons, part of the promoter region and three introns of the Aprt gene in 63 clones recovered from Pms2 7/7 mice and detected point mutations in 51. This indicates that the increase in the frequency of DAP r T cells was primarily the consequence of point mutation. Strikingly, more than half of the mutations in Pms2 7/7 mice were T to C transitions (Table 3 ). This predominance of TA to CG transitions is consistent with the mutational spectrum of Hprt in Pms2 7/7 mice (Shaddock et al., 2001) , but is in contrast to the mutational spectrum observed in lacI of Pms2 7/7 mice (Andrew et al., 1997 , BarossFrancis et al., 2001 , in which CG to TA transitions predominate.
In addition to base substitution, eight frameshift mutations at di-or mononucleotide runs were detected in class II clones recovered from Pms 7/7 mice (Table 3, Figure 2 ).
Four of the 51 (8%) clones that were con®rmed to have point mutation were putative sib clones (having the same mutation), indicating that most of mutants had originated independently. Thus, the higher frequency of T cell variants in Pms2 7/7 mice is caused by an increased mutation rate.
We also estimated the frequency of 6-TG resistant (HPRT-de®cient) T cells in of the Hprt gene, 33 kb (Melton et al., 1984) vs 3 kb for Aprt (Dush et al., 1985) , and certain unique structures, such as the six G repeat, may make it more unstable than Aprt in the absence of MMR. mice and characterized the mutational spectrum of mice. In general, the absolute frequency of clones derived from mitotic recombination is not signi®cantly dierent between Pms2 +/+ and Pms2 7/7 mice. Since the assay using Aprt as a reporter is based on the clonal proliferation of mutant cells in vitro, we were unable to extend our observations to other tissues, such as intestinal epithelium. However, with the two types of tissue we examined, we can conclude that the Pms2 7/7 mutator phenotype is tissue-dependent. Our ®ndings are in contrast to a study using supF or supFG1 transgenic mice, in which spleen and skin tissues of Pms2 7/7 mice exhibited equal elevation in mutation frequency (Narayanan et al., 1997) , but are consistent with a study of Msh2 7/7 lacI transgenic mice in which lacI showed a greater magnitude of increase in mutation frequency in thymus than in brain compared to Msh2 +/+ mice, 15.2-fold and 4.8-fold respectively (Andrew et al., 1997) .
Fibroblasts of Pms2
It is unclear as to why point mutation is dierentially elevated in dierent tissues of Pms2 7/7 mice. One possible explanation may relate to the proliferation history of each tissue. A recent study showed that quiescent mouse cells do not repair premutatgenic damage and that mutation frequency is not changed during quiescence (Bielas and Heddle, 2000) . DNA repair and increase of mutation frequency were observed only when quiescent cells were induced to proliferate. Thus, proliferation is required for both repair and mutation ®xation. Since mismatches in DNA are primarily introduced during DNA replication, via misincorporation or slippage, the accumulation of DNA replication errors in a cell may be a function of the number of prior cell divisions. Possibly, ear ®broblasts undergo fewer cell divisions than peripheral T cells in vivo, so that their chances of accumulating replication errors are reduced in comparison.
The primary function of MMR is to maintain genomic integrity. Thus, it is likely that tumor proneness displayed by the MMR-de®cient mice is driven by increased genetic instability, which can render key tumor suppressor genes more mutable. However, previous studies using microsatellite repeat and transgenic reporters showed that tumor spectrum and genetic instability are not necessarily correlated. For example, although Pms2 7/7 mice are predominantly predisposed to lymphomas, the mutation frequencies of supF and supFG1 are equally elevated in the skin and spleen tissues of those mice (Narayanan et al., 1997) . Also, whereas both Pms2
and Mlh1 7/7 mice exhibit microsatellite instability in intestinal tissues, only Mlh1 7/7 mice are predisposed to intestinal carcinoma (Prolla et al., 1998) . Thus, it is possible that the tissue-speci®c tumor proneness in MMR-de®cient mice is not solely determined by an increased level of genomic instability. Alternatively, the transgenic and microsatellite reporters may have not adequately re¯ected genetic changes at endogenous loci.
Our study showed that Aprt exhibits a dierent spectrum of point mutations in comparison to that of lacI. While more than half (55%) of the point mutations are T to C transitions at Aprt of Pms2 7/7 mice, only 14% are caused by TA to CG transitions at lacI (Baross-Francis et al., 2001) . Also, deletions and insertions at mononucleotide runs account for 15% of the point mutations at Aprt, but such frameshift mutations account for 34% at lacI (Baross-Francis et al., 2001) . Interestingly, another endogenous reporter gene, Hprt, displays a similar spectrum as Aprt in Pms2 7/7 mice (Shaddock et al., 2001) . MMR proteins in yeast and possibly mice also have anti-recombination activity, which suppresses recombination between divergent DNA sequences (Harfe and Jinks-Robertson, 2000, Shao et al., 2001) . Loss of MMR in yeast usually results in increased homologous recombination (Harfe and Jinks-Robertson, 2000) . It appears from the present study that mitotic recombination between the two homologues of chromosome 8, derived from strain 129 and strain C3H, respectively, is not aected in Pms2 7/7 mice. Probably, PMS2 is not involved in the recognition and processing of the recombination heteroduplex during mitotic recombination. Alternatively, the sequence dissimilarity between the two strains may not be sucient to produce a signi®cant inhibitory eect on recombination. Studies with other MMR gene knockout mice, such as Msh2 7/7 and Mlh1 7/7 mice, will address these questions.
Materials and methods
Mice
Production of Pms2-de®cient and Aprt-de®cient mice (both using D3 embryonic stem cells of 129/Sv mouse origin) has been described (Baker et al., 1995 , Engle et al., 1996 . The targeted (mutant) Aprt allele contains a neo insertion in exon 3, making it easily distinguishable from the wild-type allele.
Pms2
+/7 mice in N5C57 background were backcrossed to 129/Sv and C3H/HeJ, respectively, for four generations to produce (N4)129Pms2 +/7 and (N4)C3HPms2 +/7 mice. 1296C3HAprt +/7 hybrid mice with dierent Pms2 genotypes were generated by crossing (N4)129Pms2 +/7 Aprt +/7 mice to (N4)C3HPms2 +/7 mice. Aprt and Pms2 genotyping were done as described (Shao et al., 1999; Baker et al., 1995) . The hybrid mice were 2 to 3 months old when sacri®ced.
Isolation of mutant clones
Splenocytes were isolated as described (Meng et al., 1998) . After being stimulated with conconavalin A overnight, the splenocytes were seeded in 96-well plates at the density of 2610 4 cells/well in the presence of 6-thioguanine (6-TG) (2 mg/ml) or 2,6-diaminopurine (DAP) (50 mg/ml). Their colony-forming eciency (CFE) was estimated by seeding four cells per well in the presence of feeder cells, which are stimulated splenocytes irradiated with 6000 rads of X-rays. Mutant T cell colonies were scored on day 10. The mutant frequency was calculated by applying Poisson statistics. Skin ®broblasts were prepared as described (Shao et al., 1999) . They were seeded in 100 mm plates (1610 6 cells/plate) containing 6-TG (5 mg/ml) or DAP (50 mg/ml) for recovery of drug-resistant cell colonies. Their CFE was estimated by plating 5 000 to 10 000 cells in the presence of 1610 6 irradiated ®broblasts. Mutant ®broblast colonies were scored on day 12.
Molecular analysis
Characterization of DAP r clones was as described (Shao et al., 1999) . Brie¯y, DAP r clones were ®rst divided into two classes by the absence (class I) or retention (class II) of the untargeted allele. Class I clones were further characterized with polymorphic microsatellite markers along chromosome 8 to determine their mechanism(s) of origin. Clones that exhibited LOH at loci distal to Aprt but remained heterozygous at loci proximal to Aprt were interpreted to be derivatives of mitotic recombination, as was previously demonstrated more rigorously (Shao et al., 1999) . Clones that did not exhibit LOH at the most distal microsatellite marker locus, D8Mit56, were interpreted to be the outcome of gene conversion or interstitial deletion. Class II clones were sequenced for all ®ve exons, introns 1, 3 and 4, and part of the promoter region of the untargeted Aprt allele for detection of point mutation.
